May 17, 2011
Researchers from the Medical College of Wisconsin are taking part in Phase IV of the international Strategic Timing of Antiretroviral Treatment clinical trial, which seeks to determine the best time for asymptomatic persons with HIV to begin taking medications. The study, called START, has a goal of enrolling 4,000 HIV-positive men and women in 30 nations. For more information, visit www.mcw.edu/publicaffairs/NewsCenter/CollegeNews/ResearcherstoparticipateinglobalAIDSclinicaltrial.htm.
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.